# OnCo record nct02498613 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02498613/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02498613", "NCT02498613" ;
  schema:name "Cediranib plus olaparib in advanced solid tumors"@en ;
  schema:alternateName "A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors"@en ;
  schema:description "This study tests cediranib with olaparib in selected advanced cancers, including triple-negative breast cancer. It asks whether the combination can shrink tumors; it is not a study of treatment after curative breast surgery."@en ;
  schema:url <https://onco.cc/trials/nct02498613/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02498613>, <https://clinicaltrials.ucsf.edu/trial/NCT02498613> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2016-08-31" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .